Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2013-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_782cc55f2f3813fe8956c7e2dcfa7f7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4bd8d0d9360797eff0e1bd81ed9b678 |
publicationDate |
2016-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2013216122-B2 |
titleOfInvention |
Sitaxsentan derivative |
abstract |
A compound represented by formula (1-1) or (1-2) or a pharmaceutically acceptable salt thereof retains the main beneficial effects of sitaxsentan while having an improved CYP inhibitory action. [In the formulas, R |
priorityDate |
2012-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |